Total investments received (USD): 40.71m
Round value (USD): 7.44m
Company: NeoPhore
Industry:
Biotech
Health services









Netherlands
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Portugal
Spain